unknown
Stage
1
Investors
About
Cullinan Therapeutics is a clinical-stage biotechnology company focused on developing targeted therapies for cancer treatment using proprietary antibody-based approaches.
Explore Cullinan Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.